Company logo

PHG - Koninklijke Philips N.V.

NYSE -> Healthcare -> Medical Devices
Amsterdam, Netherlands
Type: Equity

PHG price evolution
PHG
(in millions $) 31 Jan 2024 30 Oct 2023 30 Jul 2023 1 May 2023
Current assets
Cash
Short term investments
Net receivables $3953 $3866
Inventory $3491 $4095
Total current assets $9940 $9686
Long term investments
Property, plant & equipment $2483 $2519
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $29406 $29506
Current liabilities
Accounts payable $1917 $1646
Deferred revenue
Short long term debt
Total current liabilities $8287 $8071
Long term debt $7035 $7177
Total noncurrent liabilities
Total debt
Total liabilities $17378 $17380
Shareholders' equity
Retained earnings $6281 $5348
Other shareholder equity $389 $1492
Total shareholder equity
(in millions $) 31 Jan 2024 31 Jan 2023 22 Feb 2022 30 Dec 2020
Current assets
Cash $1227.6 $2299.59 $3226
Short term investments $653.6 $555.18
Net receivables $3953 $4337 $3961.12 $4561
Inventory $3491 $4049 $3444.88 $2993
Total current assets $9940 $10259 $10331.66 $11227
Long term investments $21398.2 $20582.43 $670
Property, plant & equipment $2483 $2638 $2695 $2682
Goodwill & intangible assets
Total noncurrent assets $18830.82
Total investments
Total assets $29406 $30688 $30914.09 $27713
Current liabilities
Accounts payable $1917 $1968 $1869.22 $2119
Deferred revenue
Short long term debt $975.17 $505.25 $886
Total current liabilities $8287 $7934 $7438.95 $7735
Long term debt $7035 $7270 $6463.4 $4757
Total noncurrent liabilities $9225.22
Total debt
Total liabilities $17378 $17439 $16497.5 $15812
Shareholders' equity
Retained earnings $6281 $8320 $9344 $7827
Other shareholder equity $389 $377 $1092 -$340
Total shareholder equity $13877.56 $14417.59 $11870
(in millions $) 31 Jan 2024 30 Oct 2023 30 Jul 2023 1 May 2023
Revenue
Total revenue $4167
Cost of revenue
Gross Profit $1756
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $2339
Operating income
Income from continuing operations
EBIT
Income tax expense -$15
Interest expense -$95
Net income
Net income -$665
Income (for common shares)
(in millions $) 31 Jan 2024 31 Jan 2023 31 Jan 2022 30 Dec 2020
Revenue
Total revenue $18169 $17827 $19535
Cost of revenue $10754
Gross Profit $7448 $7232 $8781
Operating activities
Research & development $1783
Selling, general & administrative $5107
Total operating expenses $7555 $7372 $17653
Operating income $1882
Income from continuing operations
EBIT $1882
Income tax expense -$73 -$113 $284
Interest expense -$411 -$154 -$160
Net income
Net income -$466 -$1608 $1187
Income (for common shares) $1187
(in millions $) 31 Jan 2024 30 Jul 2023 31 Jan 2023 30 Jul 2022
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing -$636 -$359 -$1487 -$877
Financing activities
Dividends paid -$2 -$1 -$412 -$350
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$848 -$168 $500 $349
Effect of exchange rate -$79 -$47 $41 $74
Change in cash and equivalents $696 -$214 -$1131 -$1045
(in millions $) 31 Jan 2024 31 Jan 2023 22 Feb 2022 30 Dec 2020
Net income $3313.08 $1187
Operating activities
Depreciation $1321.04 $938
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations $1625.59 $2689
Investing activities
Capital expenditures -$761.87 -$513
Investments -$66
Total cash flows from investing -$636 -$1487 -$3667.55 -$1316
Financing activities
Dividends paid -$2 -$412 -$1
Sale and purchase of stock
Net borrowings $4113.89 $783
Total cash flows from financing -$848 $500 -$2344.52 $483
Effect of exchange rate -$79 $41 -$55
Change in cash and equivalents $696 -$1131 -$1200.44 $1801
Fundamentals
Market cap $18.13B
Enterprise value N/A
Shares outstanding 906.40M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 1.20
Quick ratio 0.78